Stockscreener 앱 받기
0.7399
0.09%
0.00065
Aptorum Group Ltd 주식(APM)의 최신 뉴스
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2024 - sharewise
Aptorum Group Narrows Losses by 59% in H1 2024, Terminates Yoov Merger Amid Market Challenges - StockTitan
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Benzinga
Aptorum Group Stock Hits 52-Week Low at $1.2 Amid Market Challenges - Investing.com India
Aptorum Group announces annual shareholder meeting details By Investing.com - Investing.com Australia
Aptorum Group announces annual shareholder meeting details - Investing.com India
Aptorum stock hits 52-week low at $1.34 amid market challenges - Investing.com India
Oil prices soar after OPEC+ delays production hike - Investing.com
Andean Precious Metals (CVE:APM) Upgraded at Desjardins - Defense World
Aptorum Group stock hits 52-week low at $1.35 amid market challenges - Investing.com Australia
Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum on September 10 - AsiaOne
Andean Precious Metals (CVE:APM) Reaches New 1-Year High Following Insider Buying Activity - MarketBeat
Oncology And Infectious Diseases Focused Aptorum Stock Skyrockets 7X On WednesdayHere's Why - MSN
Aptorum Group Limited (NASDAQ:APM) Sees Large Growth in Short Interest - Defense World
Aptorum Group Limited (NASDAQ:APM) Short Interest Down 47.1% in July - Defense World
Aptorum Group Limited (NASDAQ:APM) Short Interest Update - Defense World
NASDAQ – Stock Price, Charts & News Today - BNN Bloomberg
Aptorum Group (NASDAQ:APM) Trading Up 0.4% - Defense World
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Benzinga
symbol__ Stock Quote Price and Forecast - CNN
US Stocks Higher; Producer Prices Rise 0.6% In February - Benzinga
Nasdaq Rises 100 Points; BJ's Wholesale Posts Weak Sales - Benzinga
Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a ... - sharewise
Aptorum and YOOV announce merger plan - Investing.com
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023 - Business Wire
Aptorum Group Limited Announces Resignation of Thomas Lee as Head of Research and Development - Marketscreener.com
Why Is Aptorum (APM) Stock Down 16% Today? - InvestorPlace
Menopause Market Size, Share And Trends Report, 2031 - SkyQuest Technology
Cotações de Ações Americanas (STOCKS) - Money Times
DelveInsight Estimates a Promising Picture of Obesity Pipeline Space Landscape as Key 100+ Pharma Companies Working in the Space - PR Newswire
Aptorum Group Updates on the Clinical Validation of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics - ACROFAN
Notice to Boustead Securities Customers Who Purchased IPOs - GlobeNewswire
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 2, 2021 - Business Wire
Aptorum GroupAPMHigh RIsk Biotech Stocks Buy, Sell, Hold Investing Analysis for the Long-run - The Market Oracle
Aptorum Gr (NASDAQ:APM) Stock Quotes, Forecast and News Summary - Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 9, 2020 - businesswire.com
Aptorum Group Limited (NASDAQ:APM) Unveils Infectious Disease Liquid Biopsy Subsidiary to Co-develop RPIDD Tech - BP Journal
Aptorum Soars 800% On Diagnostic Testing Launch - Benzinga
Aptorum Group Ltd (NASDAQ:APM) Pleased To Unveil Video Indicating Positive Results On SACT-1 - BP Journal
Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA Bacteraemia against Linezolid and Vancomycin Respectively in In Vivo Models - Business Wire
Yam for maam: Aptorum Group to launch women’s bone health supplement made from Chinese yam - NutraIngredients-Asia
Aptorum Group Announces Significant Progress of Repurposed Drug Candidate, SACT-1 for Neuroblastoma Targeting IND Submission in H2 2020 - AsiaOne
Aeneas Capital and Pyrinas Target Launch of US$120m Fund to Develop Co-Working Laboratory Ecosystems for Life Sciences Start-Ups in the United States - BioSpace
Argus Research Initiates Equity Research Report Coverage on Aptorum Group Limited (NasdaqGM: APM) - GlobeNewswire
Hong Kong pharma start-up joins Singapore technology agency in venture fund - South China Morning Post
USD$90 million initiative between A*Star, Aptorum Group and Aeneas Capital to drive healthcare innovations - Agency for Science, Technology and Research (A*STAR)
Aptorum Group (APM) Stock Price, News & Analysis - MarketBeat
APM Stock Price and Chart — NASDAQ:APM - TradingView
Is biotech in Hong Kong doomed to fail, despite the sector’s potential? - South China Morning Post
2.88%
2.65%
자본화:
|
볼륨(24시간):